NEW YORK, May 1, 2024 /CNW/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, proudly announces support for the reports citing the Drug Enforcement Agency's ("DEA") decision to accept the recommendation of the U.S. Department of Health and Human Services ("HHS") to move cannabis from Schedule I to Schedule III of the Controlled Substances Act ("CSA").
Read more at newswire.cahello world
Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.
